drug · small molecule
paltusotine hydrochloride
Marketedupdated 3mo agoby $CRNX Crinetics Pharmaceuticals, Inc.🔗 ChEMBL
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 3Small molecule drug with a maximum clinical stage of Unknown (across all indications), with 3 investigational indications.
all catalysts(1)
Patent cliff
source: FDA Orange Bookfirst barrier falls
Sep 25, 2030
~4.1 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (18)
- Mar 25, 2044method-of-use (U-4282)US 12208092
- Mar 25, 2044method-of-use (U-4282)US 12208092
- Sep 7, 2041formulationUS 11266641
- Sep 7, 2041formulationUS 11266641
- Sep 7, 2041method-of-use (U-4283)US 11957674
- Sep 7, 2041method-of-use (U-4283)US 11957674
- Jan 16, 2039compositionUS 10464918
- Jan 16, 2039compositionUS 10464918
- Jul 12, 2037compositionUS 10351547
- Jul 12, 2037compositionUS 10351547
- Jul 12, 2037compositionUS 10597377
- Jul 12, 2037compositionUS 10597377
- Jul 12, 2037method-of-use (U-4283)US 10875839
- Jul 12, 2037method-of-use (U-4283)US 10875839
- Jul 12, 2037compositionUS 11414397
- Jul 12, 2037compositionUS 11414397
- Jul 12, 2037compositionUS 9896432
- Jul 12, 2037compositionUS 9896432
FDA exclusivities (2)
- Sep 25, 2030NCENew Chemical Entity (5y)4.1y
- Sep 25, 2030NCENew Chemical Entity (5y)4.1y
News(3)
- Vertex to acquire Crinetics in $10B foray into endocrine disease drugsVertex claimed the two drugs in the deal could eventually bring in more than $5 billion annually. Still, the high price it paid stirred debate among analysts and investors.biopharma_dive · 1mo ago
- STAT+: Pharmalittle: We’re reading about a $10 billion Vertex deal, the pace of FDA drug approvals, and moreVertex Pharmaceuticals will spend $10 billion to acquire Crinetics Pharmaceuticals and its drug for a rare endocrine disorderstat · 1mo ago
- STAT+: Vertex acquires Crinetics Pharmaceuticals for $10 billion as biotech M&A boomsVertex Pharmaceuticals will spend $10 billion to acquire Crinetics Pharmaceuticals and its drug for a rare endocrine disorder, the companies said.stat · 1mo ago
Data sources
last refreshed 21m ago
Found something off?
comments(0)
5-min edit window · permanent after that